COVID-19 cytokine storm: what is in a name?
Ann Rheum Dis
.
2021 Jan;80(1):3-5.
doi: 10.1136/annrheumdis-2020-219448.
Epub 2020 Nov 17.
Author
Peter A Nigrovic
1
2
Affiliations
1
Division of Immunology, Boston Children's Hospital, Boston, Massachusetts, USA peter.nigrovic@childrens.harvard.edu.
2
Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, USA.
PMID:
33203641
DOI:
10.1136/annrheumdis-2020-219448
No abstract available
Keywords:
COVID-19; cytokines; inflammation.
Publication types
Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment
MeSH terms
COVID-19*
Cytokine Release Syndrome
Cytokines
Humans
SARS-CoV-2
Substances
Cytokines
Grants and funding
R01 AR065538/AR/NIAMS NIH HHS/United States
R01 AR075906/AR/NIAMS NIH HHS/United States
R01 AR073201/AR/NIAMS NIH HHS/United States
P30 AR070253/AR/NIAMS NIH HHS/United States
R21 AR076630/AR/NIAMS NIH HHS/United States
R21 HL150575/HL/NHLBI NIH HHS/United States